Facing vial shortage, pharmas explore workarounds for coronavirus vaccines

The world will likely need billions of doses of any vaccine that's proven safe and effective against the new coronavirus. But there's not enough glass vials to hold all those doses, creating another supply headache for drugmakers to solve as they work feverishly to complete clinical testing in record time.